Literature DB >> 24107129

A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties.

James M Murphy, Qingwei Zhang1, Samuel N Young2, Michael L Reese3, Fiona P Bailey4, Patrick A Eyers4, Daniela Ungureanu5, Henrik Hammaren5, Olli Silvennoinen5, Leila N Varghese, Kelan Chen, Anne Tripaydonis2, Natalia Jura6, Koichi Fukuda7, Jun Qin7, Zachary Nimchuk8, Mary Beth Mudgett9, Sabine Elowe10, Christine L Gee11, Ling Liu12, Roger J Daly12, Gerard Manning13, Jeffrey J Babon, Isabelle S Lucet1.   

Abstract

Protein kinase-like domains that lack conserved residues known to catalyse phosphoryl transfer, termed pseudokinases, have emerged as important signalling domains across all kingdoms of life. Although predicted to function principally as catalysis-independent protein-interaction modules, several pseudokinase domains have been attributed unexpected catalytic functions, often amid controversy. We established a thermal-shift assay as a benchmark technique to define the nucleotide-binding properties of kinase-like domains. Unlike in vitro kinase assays, this assay is insensitive to the presence of minor quantities of contaminating kinases that may otherwise lead to incorrect attribution of catalytic functions to pseudokinases. We demonstrated the utility of this method by classifying 31 diverse pseudokinase domains into four groups: devoid of detectable nucleotide or cation binding; cation-independent nucleotide binding; cation binding; and nucleotide binding enhanced by cations. Whereas nine pseudokinases bound ATP in a divalent cation-dependent manner, over half of those examined did not detectably bind nucleotides, illustrating that pseudokinase domains predominantly function as non-catalytic protein-interaction modules within signalling networks and that only a small subset is potentially catalytically active. We propose that henceforth the thermal-shift assay be adopted as the standard technique for establishing the nucleotide-binding and catalytic potential of kinase-like domains.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24107129      PMCID: PMC5679212          DOI: 10.1042/BJ20131174

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  73 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 2.  Dawn of the dead: protein pseudokinases signal new adventures in cell biology.

Authors:  Patrick A Eyers; James M Murphy
Journal:  Biochem Soc Trans       Date:  2013-08       Impact factor: 5.407

3.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis.

Authors:  Jie Zhao; Siriporn Jitkaew; Zhenyu Cai; Swati Choksi; Qiuning Li; Ji Luo; Zheng-Gang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

4.  In vitro JAK kinase activity and inhibition assays.

Authors:  Jeffrey J Babon; James M Murphy
Journal:  Methods Mol Biol       Date:  2013

5.  Identification of an acquired JAK2 mutation in polycythemia vera.

Authors:  Runxiang Zhao; Shu Xing; Zhe Li; Xueqi Fu; Qingshan Li; Sanford B Krantz; Zhizhuang Joe Zhao
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

6.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.

Authors:  Natalia Jura; Yibing Shan; Xiaoxian Cao; David E Shaw; John Kuriyan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

Review 8.  Receptor tyrosine kinases with intracellular pseudokinase domains.

Authors:  Jeannine M Mendrola; Fumin Shi; Jin H Park; Mark A Lemmon
Journal:  Biochem Soc Trans       Date:  2013-08       Impact factor: 5.407

9.  Integrin-linked kinase is an adaptor with essential functions during mouse development.

Authors:  Anika Lange; Sara A Wickström; Madis Jakobson; Roy Zent; Kirsi Sainio; Reinhard Fässler
Journal:  Nature       Date:  2009-10-15       Impact factor: 49.962

10.  Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation.

Authors:  Elton Zeqiraj; Beatrice Maria Filippi; Maria Deak; Dario R Alessi; Daan M F van Aalten
Journal:  Science       Date:  2009-11-05       Impact factor: 47.728

View more
  105 in total

Review 1.  PseudoGTPase domains in p190RhoGAP proteins: a mini-review.

Authors:  Amy L Stiegler; Titus J Boggon
Journal:  Biochem Soc Trans       Date:  2018-12-04       Impact factor: 5.407

2.  Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2).

Authors:  Xiaoshan Min; Daniela Ungureanu; Sarah Maxwell; Henrik Hammarén; Steve Thibault; Ellin-Kristina Hillert; Merrill Ayres; Brad Greenfield; John Eksterowicz; Chris Gabel; Nigel Walker; Olli Silvennoinen; Zhulun Wang
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

3.  STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1.

Authors:  Izabela Durzynska; Xiang Xu; Guillaume Adelmant; Scott B Ficarro; Jarrod A Marto; Piotrek Sliz; Sacha Uljon; Stephen C Blacklow
Journal:  Structure       Date:  2017-01-12       Impact factor: 5.006

4.  ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation.

Authors:  Henrik M Hammarén; Daniela Ungureanu; Jean Grisouard; Radek C Skoda; Stevan R Hubbard; Olli Silvennoinen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

Review 5.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

6.  Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences.

Authors:  E Waanders; B Scheijen; M C J Jongmans; H Venselaar; S V van Reijmersdal; A H A van Dijk; A Pastorczak; R D A Weren; C E van der Schoot; M van de Vorst; E Sonneveld; N Hoogerbrugge; V H J van der Velden; B Gruhn; P M Hoogerbrugge; J J M van Dongen; A Geurts van Kessel; F N van Leeuwen; R P Kuiper
Journal:  Leukemia       Date:  2016-10-13       Impact factor: 11.528

Review 7.  Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death.

Authors:  James M Murphy; John Silke
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

8.  The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization.

Authors:  Byung Hak Ha; Titus J Boggon
Journal:  J Biol Chem       Date:  2017-12-06       Impact factor: 5.157

9.  The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis.

Authors:  Claudia Günther; Gui-Wei He; Andreas E Kremer; James M Murphy; Emma J Petrie; Kerstin Amann; Peter Vandenabeele; Andreas Linkermann; Christopher Poremba; Ulrike Schleicher; Christin Dewitz; Stefan Krautwald; Markus F Neurath; Christoph Becker; Stefan Wirtz
Journal:  J Clin Invest       Date:  2016-10-17       Impact factor: 14.808

10.  The NS1 Protein of Influenza A Virus Participates in Necroptosis by Interacting with MLKL and Increasing Its Oligomerization and Membrane Translocation.

Authors:  Amit Gaba; Fang Xu; Yao Lu; Hong-Su Park; GuanQun Liu; Yan Zhou
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.